Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
MindWalk Holdings Corp
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotherapeutic research company. It is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its...
operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. It is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 03, 2025 8:49am
New Press Release - ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to "HYFT"
An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 02, 2025 8:01am
New Press Release - ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright Global Investment Conference, taking place September 8th through September 10th, 2025. Dr. Jennifer Bath, President CEO of IPA, will deliver a company...
read article.
DiagnosTear Announces Clinical Study with AlyaTec
posted Dec 04, 2025 9:00am by
Diagnostear Technologies Inc
-
|
TeaRx™ Red Eye is being developed as the first rapid, multi-biomarker diagnostic test designed to differentiate between Adenoviral conjunctivitis, Herpetic keratitis, and Allergic conjunctivitis at the point of care. These three conditions drive hundreds of millions of clinic visits every year, yet misdiagnosis remains widespread due to the absence of fast, accurate testing. TeaRx™ aims to change that with a simple test that delivers clinical answers in minutes. ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 27, 2025 8:22am
New Press Release - ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation
Manufacturing of validated dengue epitope underway; proprietary immunization studies in rabbit model to assess monoclonal antibody (mAb) responses. ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug...
read article.
(6)
•••
Wiz666000
X
Comment by
Wiz666000
on Aug 20, 2025 11:06pm
RE:$3/ share then look out.
Been a while and it should be worth the wait. These stocks could explode at any time. Good luck to everyone and even the new ones that will come aboard.
(29)
•••
wallpaper2
X
Post by
wallpaper2
on Aug 20, 2025 10:11pm
$3/ share then look out.
A Billion$$ Market Cap is very realistic. 1 Billion is a minimum at that!
(29)
•••
wallpaper2
X
Post by
wallpaper2
on Aug 18, 2025 1:31pm
Where is Dart321
He said IPA would be delisted from Nasdaq and end up on the Cse. lol
(249)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Aug 18, 2025 10:55am
Using technical analysis for this stock.
It is starting a new uptrend for shareholders today so good luck to all of you
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 06, 2025 8:01am
New Press Release - ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies (Europe) B.V. (“IPA Europe”), to AVS Bio...
read article.
(11)
•••
BryceCanada
X
Post by
BryceCanada
on Jul 29, 2025 12:44pm
Earnings out!!
https://youtu.be/PEb59xElRQM?si=rt4hgmawg1jrvHFX
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 29, 2025 8:28am
New Press Release - ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA
ImmunoPrecise Antibodies Ltd. (“IPA”, “Company”, “we” or “us”) (NASDAQ: IPA), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announces its financial results for the fiscal year ended April 30, 2025. All numbers are expressed in Canadian...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 24, 2025 8:23am
New Press Release - ImmunoPrecise Releases New Findings Showing LENSai(TM) Quickly Flags Anti-Drug-Antibody Risk-Long Before the Clinic
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, today announced results of a newly expanded study demonstrating that its LENSai™ Immunogenicity Screening can reliably predict Anti-Drug...
read article.
(11)
•••
BryceCanada
X
Post by
BryceCanada
on Jul 23, 2025 7:14pm
New video Jul 23
https://youtu.be/4i5Xf0bMBv4?si=lRv10VCYSXgQFKEt
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 21, 2025 8:28am
New Press Release - ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment of Jeff Fried to its Advisory Board. A recognized leader in healthcare data infrastructure...
read article.
(29)
•••
wallpaper2
X
Comment by
wallpaper2
on Jul 17, 2025 8:01pm
RE:Wallpaper
I don't think they are referring to progress reports or updates. IPA seems to avoid giving shareholders updates on any of their existing collaborations or partnerships. They cite
...more
(4)
•••
Paparico1
X
Post by
Paparico1
on Jul 17, 2025 6:45am
Wallpaper
I thought I read somewhere but only found this "Unlike traditional methods that take months and require lab work, LENSai delivers results in hours " I thought I read what took a year
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Building Momentum in One of the World's Most Prospective Copper Regions
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)
A Company Focused on Developing Functional Healthier “Better For You” Foods
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland